S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.81 (-1.44%)
MSFT   420.81 (-0.15%)
META   488.88 (-1.01%)
GOOGL   150.71 (-0.11%)
AMZN   181.18 (+0.75%)
TSLA   176.32 (-1.95%)
NVDA   904.81 (+0.26%)
NIO   4.61 (-1.28%)
AMD   181.59 (+1.11%)
BABA   72.52 (+1.30%)
T   17.57 (+0.11%)
F   13.30 (+1.84%)
MU   118.60 (-0.45%)
CGC   9.75 (+2.09%)
GE   175.30 (-2.68%)
DIS   122.96 (+1.64%)
AMC   3.71 (-14.52%)
PFE   27.87 (+0.32%)
PYPL   66.82 (+0.38%)
XOM   115.50 (+0.46%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.81 (-1.44%)
MSFT   420.81 (-0.15%)
META   488.88 (-1.01%)
GOOGL   150.71 (-0.11%)
AMZN   181.18 (+0.75%)
TSLA   176.32 (-1.95%)
NVDA   904.81 (+0.26%)
NIO   4.61 (-1.28%)
AMD   181.59 (+1.11%)
BABA   72.52 (+1.30%)
T   17.57 (+0.11%)
F   13.30 (+1.84%)
MU   118.60 (-0.45%)
CGC   9.75 (+2.09%)
GE   175.30 (-2.68%)
DIS   122.96 (+1.64%)
AMC   3.71 (-14.52%)
PFE   27.87 (+0.32%)
PYPL   66.82 (+0.38%)
XOM   115.50 (+0.46%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.81 (-1.44%)
MSFT   420.81 (-0.15%)
META   488.88 (-1.01%)
GOOGL   150.71 (-0.11%)
AMZN   181.18 (+0.75%)
TSLA   176.32 (-1.95%)
NVDA   904.81 (+0.26%)
NIO   4.61 (-1.28%)
AMD   181.59 (+1.11%)
BABA   72.52 (+1.30%)
T   17.57 (+0.11%)
F   13.30 (+1.84%)
MU   118.60 (-0.45%)
CGC   9.75 (+2.09%)
GE   175.30 (-2.68%)
DIS   122.96 (+1.64%)
AMC   3.71 (-14.52%)
PFE   27.87 (+0.32%)
PYPL   66.82 (+0.38%)
XOM   115.50 (+0.46%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.81 (-1.44%)
MSFT   420.81 (-0.15%)
META   488.88 (-1.01%)
GOOGL   150.71 (-0.11%)
AMZN   181.18 (+0.75%)
TSLA   176.32 (-1.95%)
NVDA   904.81 (+0.26%)
NIO   4.61 (-1.28%)
AMD   181.59 (+1.11%)
BABA   72.52 (+1.30%)
T   17.57 (+0.11%)
F   13.30 (+1.84%)
MU   118.60 (-0.45%)
CGC   9.75 (+2.09%)
GE   175.30 (-2.68%)
DIS   122.96 (+1.64%)
AMC   3.71 (-14.52%)
PFE   27.87 (+0.32%)
PYPL   66.82 (+0.38%)
XOM   115.50 (+0.46%)
NASDAQ:SPRC

SciSparc (SPRC) Stock Price, News & Analysis

$1.76
+0.02 (+1.14%)
(As of 11:27 AM ET)
Today's Range
$1.72
$1.77
50-Day Range
$1.74
$6.16
52-Week Range
$1.72
$23.66
Volume
45,769 shs
Average Volume
1.11 million shs
Market Capitalization
$915,148.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SPRC stock logo

About SciSparc Stock (NASDAQ:SPRC)

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and epilepsy and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation, as well as a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. The company was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

SPRC Stock Price History

SPRC Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Why Is SciSparc (SPRC) Stock Up 50% Today?
See More Headlines
Receive SPRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SciSparc and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SPRC
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.35 million
Cash Flow
$21.75 per share
Book Value
$54.18 per share

Miscellaneous

Free Float
516,000
Market Cap
$904,800.00
Optionable
Not Optionable
Beta
0.76
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Itschak Shrem (Age 77)
    President & Director
    Comp: $219k
  • Dr. Adi Zuloff-Shani Ph.D. (Age 55)
    Chief Technologies Officer
    Comp: $274k

SPRC Stock Analysis - Frequently Asked Questions

How have SPRC shares performed in 2024?

SciSparc's stock was trading at $4.88 on January 1st, 2024. Since then, SPRC shares have decreased by 64.2% and is now trading at $1.7460.
View the best growth stocks for 2024 here
.

When is SciSparc's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our SPRC earnings forecast
.

When did SciSparc's stock split?

SciSparc's stock reverse split before market open on Thursday, September 28th 2023. The 1-26 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of SciSparc?

Shares of SPRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SPRC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners